SEC Filing: Form 425
Prospectuses and communications, business combinations
VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
Prospectuses and communications, business combinations
Current report
Prospectuses and communications, business combinations
Statement of changes in beneficial ownership of securities – amendment
Statement of changes in beneficial ownership of securities – amendment
Statement of changes in beneficial ownership of securities – amendment